Option chain shows key data for FibroBiologics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for FibroBiologics.

FibroBiologics (NASDAQ:FBLG) Stock, Option Chain

FIBROBIOLOGICS INC

FibroBiologics, Inc. - Common Stock

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Stock market analysts

News

Initiation

Markets

Analyst Ratings

Trading Ideas

CARM

FBLG

IVVD

This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday

Image22

Pre-Market Outlook

Movers

BBCP

BMEA

DOCU

FTEL

REPL

Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday&#39;s Pre-Market Session

xr:d:DAFtH5xd8iU:2,j:4016486423666345323,t:23083115

Intraday Update

AMBC

ASNS

BGXX

BNED

CLEU

CMPS

CVAC

DLTR

DOYU

FRES

GDHG

GWRE

HLTH

JDZG

JEWL

MITQ

MLGO

MMYT

MNMD

MPLN

MYND

NDRA

NVAX

NVVE

OLLI

SFIX

SGRP

SILO

SOBR

SYTA

THMO

UMAC

UNFI

VLCN

VRNT

VSTE

WKME

XTIA

Why Lands&#39; End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

FibroBiologics Inc

Health Care

Legal

Press Releases

General

FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics

Life Sciences Investor Forum Agenda Announced for March 13th

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting

FibroBiologics Announces 2025 Annual Meeting of Stockholders

Earnings

FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

FibroBiologics Presenting at the ThymUS 2025 Meeting

AVCNF

BPTSY

CGTX

COCP

CSE:IZO

CSE:TELI

HMTXF

IZOZF

LADX

NGENF

PDSB

RAFA

TELIF

TNXP

TSX:AVCN

TSXV:HEM

TSXV:NGEN

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Aligos Therapeutics

Allakos

Annovis Bio

BioAtla

bluebird bio

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroBiologics

FibroGen

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

MiNK Therapeutics

Kezar Life Sciences

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Rein Therapeutics

RenovoRx

Spero Therapeutics

Surrozen

Xilio Therapeutics

D. Boral Capital

HC Wainwright & Co.

Rodman & Renshaw

EF Hutton

Maxim Group

Comments

FibroBiologics

FibroBiologics (FBLG) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell